- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The influence of diet on anti-cancer immune responsiveness ; volume:16 ; number:1 ; day:20 ; month:3 ; year:2018 ; pages:1-18 ; date:12.2018
Journal of translational medicine ; 16, Heft 1 (20.3.2018), 1-18, 12.2018
- Urheber
-
Soldati, Laura
- Beteiligte Personen und Organisationen
-
Di Renzo, Laura
Jirillo, Emilio
Ascierto, Paolo A.
Marincola, Francesco M.
De Lorenzo, Antonino
SpringerLink (Online service)
- DOI
-
10.1186/s12967-018-1448-0
- URN
-
urn:nbn:de:1111-2018052026724
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Soldati, Laura
- Di Renzo, Laura
- Jirillo, Emilio
- Ascierto, Paolo A.
- Marincola, Francesco M.
- De Lorenzo, Antonino
- SpringerLink (Online service)
Ähnliche Objekte (12)
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
What have we learned from cancer immunotherapy in the last 3 years?
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Combination therapy: the next opportunity and challenge of medicine
Melanoma: A model for testing new agents in combination therapies
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer
Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
The immune score as a new possible approach for the classification of cancer
Lean oncology: a new model for oncologists
Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
What have we learned from cancer immunotherapy in the last 3 years?
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Combination therapy: the next opportunity and challenge of medicine
Melanoma: A model for testing new agents in combination therapies
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer
Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
The immune score as a new possible approach for the classification of cancer
Lean oncology: a new model for oncologists
Overall survival of patients with chemotherapy-naive advanced melanoma treated with ipilimumab 3 mg/kg in clinical trials
Melanoma: the role of surgery in the era of new therapies
Adjuvant therapy of melanoma with interferon: lessons of the past decade
What have we learned from cancer immunotherapy in the last 3 years?
Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?
Combination therapy: the next opportunity and challenge of medicine
Melanoma: A model for testing new agents in combination therapies
Anti-CTLA4 monoclonal antibodies: the past and the future in clinical application
Highlights and summary of the 28th annual meeting of the Society for Immunotherapy of Cancer
Systematic review of the use of granulocyte–macrophage colony-stimulating factor in patients with advanced melanoma
The immune score as a new possible approach for the classification of cancer
Lean oncology: a new model for oncologists